Denali Therapeutics
The Director, Site Operations & Strategic Execution serves as a key operational leader within the Salt Lake City organization, responsible for driving the site operating model and enabling execution excellence across strategic initiatives and manufacturing readiness activities. This role partners closely with cross-functional teams to ensure operational alignment, organizational scalability, and disciplined execution as the company scales toward late-stage and commercial operations. The position focuses on establishing governance processes, performance management frameworks, and strategic execution capabilities to support reliable and inspection-ready operations.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
Denali Therapeutics didn’t post a salary, so this is our estimate from similar listings.